Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Premenstrual syndrome – pipeline review, h1 2012


Published on

Aarkstore Enterprise-Premenstrual Syndrome – Pipeline Review, H1 2012|| Market Research

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

Premenstrual syndrome – pipeline review, h1 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Premenstrual Syndrome – Pipeline Review, H1 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s, Premenstrual Syndrome - Pipeline Review, H1 2012,provides an overview of the Premenstrual Syndrome therapeutic pipeline. Thisreport provides information on the therapeutic development for PremenstrualSyndrome, complete with latest updates, and special features on late-stage anddiscontinued projects. It also reviews key players involved in the therapeuticdevelopment for Premenstrual Syndrome. Premenstrual Syndrome - PipelineReview, H1 2012 is built using data and information sourced from Global MarketsDirect’s proprietary databases, Company/University websites, SEC filings, investorpresentations and featured press releases from company/university sites andindustry-specific third party sources, put together by Global Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Premenstrual Syndrome.- A review of the Premenstrual Syndrome products under development bycompanies and universities/research institutes based on information derived fromcompany and industry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.
  2. 2. - A feature on pipeline projects on the basis of monotherapy and combinedtherapeutics.Table of contents:List of Tables 3List of Figures 4Introduction 5Global Markets Direct Report Coverage 5Hypercalcemia Overview 6Therapeutics Development 7An Overview of Pipeline Products for Hypercalcemia 7Hypercalcemia Therapeutics under Development by Companies 9Hypercalcemia Therapeutics under Investigation by Universities/Institutes 10Mid Clinical Stage Products 11Comparative Analysis 11Early Clinical Stage Products 12Comparative Analysis 12Hypercalcemia Therapeutics – Products under Development by Companies 13Hypercalcemia Therapeutics – Products under Investigation byUniversities/Institutes 14Companies Involved in Hypercalcemia Therapeutics Development 15Med Discovery SA 15Hypercalcemia – Therapeutics Assessment 16Assessment by Monotherapy Products 16Assessment by Route of Administration 17Assessment by Molecule Type 19Drug Profiles 21Parathyroid Hormone (1-34) - Drug Profile 21Product Description 21Mechanism of Action 21R&D Progress 21MDAB16 - Drug Profile 23Product Description 23Mechanism of Action 23R&D Progress 23
  3. 3. Hypercalcemia Therapeutics - Dormant Products 24List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H1 2012 Review, H12012&PubId=&pagenum=1Vasculitis – Pipeline Review, H1 2012Wrinkles – Pipeline Review, H1 2012Premenstrual Syndrome – Pipeline Review, H1 2012Hypercalcemia – Pipeline Review, H1 2012Chicken Pox – Pipeline Review, H1 2012Hypereosinophilic Syndrome – Pipeline Review, H1 2012Familial Adenomatous Polyposis Coli – Pipeline Review, H1 2012Tinnitus – Pipeline Review, H1 2012Shock – Pipeline Review, H1 2012
  4. 4. Influenza B Infections – Pipeline Review, H1 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: